SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Overview
BIT:1SRPT - US8036071004 - Common Stock
1SRPT.MI Key Statistics, Chart & Performance
The current stock price of 1SRPT.MI is 15.495 EUR.
1SRPT.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 19.74 | 316.57B | ||
| 1ABBV.MI | ABBVIE INC | 19.14 | 314.07B | ||
| AMG.DE | AMGEN INC | 13.1 | 131.93B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 14.46 | 122.10B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.49 | 119.42B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.06 | 85.89B | ||
| ARGX.BR | ARGENX SE | 81.51 | 36.96B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.70B | ||
| IDP.DE | BIOGEN INC | 8.27 | 16.64B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.13B | ||
| 0QF.DE | MODERNA INC | N/A | 7.95B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.52B |
Related stock screener links
About 1SRPT.MI
Company Profile
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 1,372 full-time employees. The firm is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. The company has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. The firm has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes over 40 programs at various stages of discovery, pre-clinical and clinical development.
Company Info
SAREPTA THERAPEUTICS INC
215 1st St Ste 415
Cambridge MASSACHUSETTS US
Employees: 1372
Phone: 16172744000
SAREPTA THERAPEUTICS INC / 1SRPT.MI FAQ
What is the stock price of SAREPTA THERAPEUTICS INC today?
The current stock price of 1SRPT.MI is 15.495 EUR. The price increased by 0.81% in the last trading session.
What is the ticker symbol for SAREPTA THERAPEUTICS INC stock?
The exchange symbol of SAREPTA THERAPEUTICS INC is 1SRPT and it is listed on the Euronext Milan exchange.
On which exchange is 1SRPT.MI stock listed?
1SRPT.MI stock is listed on the Euronext Milan exchange.
What is SAREPTA THERAPEUTICS INC worth?
SAREPTA THERAPEUTICS INC (1SRPT.MI) has a market capitalization of 1.52B EUR. This makes 1SRPT.MI a Small Cap stock.
How many employees does SAREPTA THERAPEUTICS INC have?
SAREPTA THERAPEUTICS INC (1SRPT.MI) currently has 1372 employees.
Is SAREPTA THERAPEUTICS INC (1SRPT.MI) expected to grow?
The Revenue of SAREPTA THERAPEUTICS INC (1SRPT.MI) is expected to grow by 3.14% in the next year. Check the estimates tab for more information on the 1SRPT.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SAREPTA THERAPEUTICS INC (1SRPT.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1SRPT.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1SRPT.MI, evaluating the profitability, health, valuation and growth aspects
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Sales and EPS estimates to see what analysts future expectations are.
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Chart to make your own analysis
- SAREPTA THERAPEUTICS INC (1SRPT.MI) Latest news and press-releases to stay up to date.
Does SAREPTA THERAPEUTICS INC (1SRPT.MI) stock pay dividends?
1SRPT.MI does not pay a dividend.
When does SAREPTA THERAPEUTICS INC (1SRPT.MI) report earnings?
SAREPTA THERAPEUTICS INC (1SRPT.MI) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of SAREPTA THERAPEUTICS INC (1SRPT.MI)?
SAREPTA THERAPEUTICS INC (1SRPT.MI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.74).
1SRPT.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1SRPT.MI.
1SRPT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1SRPT.MI. 1SRPT.MI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
1SRPT.MI Financial Highlights
Over the last trailing twelve months 1SRPT.MI reported a non-GAAP Earnings per Share(EPS) of -0.74. The EPS decreased by -293.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.57% | ||
| ROE | -4.27% | ||
| Debt/Equity | 0.84 |
1SRPT.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of -282.9% and a revenue growth 3.14% for 1SRPT.MI